• SENSEX 73,380.91
    -217.76 (--0.30%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,161.90 1,152.30(%)
  • Piramal Pharma
    234.35 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • Cholaman.Inv.&Fn
    1,533.35 1,952.00(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • One 97
    1,599.20 947.10(%)
  • Ola Electric
    37.44 51.84(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Sahajanand Medi
    491.15 347.50(%)
  • Patanjali Foods
    351.70 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • OneSource Speci.
    1,561.70 1,075.00(%)
  • Infosys
    1,103.50 980.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Piramal Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Ajay G
  • BSE Code : 76066.0
  • ISIN : INE0DK501011
198.72 4 (1.82%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    194.61

  • Today’s High

    203.37

  • Open

    196.08

  • Perv Close

    195.17

  • 52W Low

    132.30

  • 52W High

    231.93

Key Indicators

  • P/E(TTM)

    34.10

  • Mar.Cap (₹Cr.)

    26,456.55

  • Div & Yield %

    0.00

  • Book Value(₹)

    61.18

  • Debt-Equity Ratio

    1.82

  • AGM Date

    27-Oct-2026

  • EPS

    5.82

  • P/E Ratio

    34.10

Financials Ratios

  • Debt-Equity Ratio

    0.70

  • Mar.Cap (₹Cr.)

    26,456.55

  • RONW (%)

    0.22

  • ROCE (%)

    5.40

Score Board

  • Equity (₹ in Cr.)

    1,331.35

  • BV (₹)

    61.20

  • Sales( ₹ in Cr.)

    4,782.01

  • NP (in Cr.)

    767.53

  • NP Var(%)

    11.0

  • Div%

    0.0

  • CPS (₹)

    7.70

  • EPS (₹)

    5.80

  • Traded Value (₹ in Lakhs)

    26,420.60

  • 52 Week High

    231.93

  • 52 Week Low

    132.30

  • Price BSE

    198.0

  • Price NSE

    199.00

  • Market Capital( in Cr.)

    26,420.60

  • P/C Ratio

    25.80

  • P/E Ratio

    34.30

  • Price Vs.BV

    5.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 4,782.01 5,285.71 4,390.11 3,443.22 3,340.42 2,938.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,782.01 5,285.71 4,390.11 3,443.22 3,340.42 2,938.81
Other Income 662.73 207.35 202.06 341.07 224.79 216.20
Stock Adjustments 138.98 84.57 61.62 -53.31 32.66 -57.86
Total Income 5,583.72 5,577.63 4,653.79 3,730.98 3,597.87 3,097.15
EXPENDITURE :            
Raw Materials 2,208.88 2,330.53 2,170.46 1,715.17 1,594.17 1,169.91
Power and Fuel Cost 131.53 131.62 112.89 107.94 83.83 68.08
Employee Cost 744.82 736.19 613.93 548.50 448.03 395.15
Other Manufacturing Expenses 292.60 284.35 251.57 259.29 299.83 252.74
Selling and Administration Expenses 746.52 746.69 620.04 485.63 427.82 258.75
Miscellaneous Expenses 247.15 100.46 64.92 182.81 59.20 117.39
Employee Benefit Expenses 744.82 736.19 613.93 548.50 448.03 395.15
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,371.50 4,329.84 3,833.81 3,299.34 2,912.88 2,262.02
Operating Profit 1,212.22 1,247.79 819.98 431.64 684.99 835.13
Interest 79.95 114.56 107.10 115.87 57.29 4.71
Gross Profit 1,132.27 1,133.23 712.88 315.77 627.70 830.42
Depreciation 255.50 222.09 205.26 192.08 165.37 143.64
Profit Before Tax 876.77 911.14 507.62 123.69 462.33 686.78
Current Tax 114.68 199.44 112.48 38.77 110.82 104.98
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 62.08 20.30 3.92 15.42 -16.03 10.30
Reported Net Profit 700.01 691.40 391.22 69.50 367.54 571.50
Extraordinary Items -67.52 2.40 3.34 -3.14 -10.64 15.44
Adjusted Net Profit 767.53 689.00 387.88 72.64 378.18 556.06
Adjustment below Net Profit -13.89 1.05 -3.79 -2.59 31.70 -2.46
P & L Balance brought forward 2,037.21 1,359.23 971.79 918.28 569.04 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 18.54 14.47 0.00 13.40 50.00 0.00
P & L Balance carried down 2,704.79 2,037.21 1,359.22 971.79 918.28 569.04
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 1.40 1.10 0.00 5.60 0.00
Dividend Per Share(Rs) 0.00 0.14 0.11 0.00 0.56 0.00
Earnings Per Share-Unit Curr 5.27 5.22 2.96 0.58 3.10 5.75
Earnings Per Share(Adj)-Unit Curr 5.27 5.22 2.96 0.57 - -
Book Value 61.34 56.27 50.74 44.09 43.20 41.23
Book Value(Adj)-Unit Curr 61.34 56.27 50.74 43.06 - -

Shareholding Pattern

  • Promoter Group

    34.80%

  • Public Share Holding

    64.80%

  • Custodian

    0.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 91,750,276 6.89 91,750,276 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,570,932 0.19 2,570,932 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 369,003,464 27.72 369,003,464 5
Others 0 0.00 0 0
Sub Total 463,324,672 34.80 463,324,672 17
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 2,659 0.00 2,659 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 9,868 0.00 9,868 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 181,743,381 13.65 181,743,381 191
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 16,432,030 1.23 16,432,030 13
Mutual Funds / UTI 169,259,414 12.71 169,259,414 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,552,900 0.49 6,552,900 30
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 374,000,252 28.09 374,000,252 266
2] Non Institution
Bodies Corporate 21,520,081 1.62 21,520,081 1,295
Clearing Members 880,337 0.07 880,337 73
Directors of their Relatives 274,433 0.02 274,433 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 17,315,548 1.30 17,315,548 2
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 15,198,159 1.14 15,198,159 6,969
Foreign Non Institution Other 238,663,700 17.93 238,663,700 1
Hindu Undivided Families 5,973,399 0.45 5,973,399 5,703
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 48,553,692 3.65 48,553,692 711
Individuals holding nominal share capital up to Rs. 1 lakh 128,100,783 9.62 128,100,783 398,038
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 28,143 0.00 28,143 11
Others 3,214,656 0.24 3,214,656 1
Sub Total 488,759,611 36.71 488,759,611 412,911
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 5,263,595 0.40 5,263,595 3
Total Shares held by Custodians and against which Depository Receipts have been issued 5,263,595 0.40 5,263,595 3
Grand Total ( A + B + C ) 1,331,348,130 100.00 1,331,348,130 413,197

Company Background

Piramal Pharma LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Piramal Pharma Ltd
  • BSE Code : 76066.0
  • ISIN : INE0DK501011

  • Incorporation Year

    2020

  • Registered Office

    Ananta Bldg Piramal Corporate
    Park LBS Marg Kurla west, Mumbai,
    Maharashtra-400070

  • Telephone

  • FAX

  • Chairman

    Nandini Piramal

  • Managing Director

  • Company Secretary

    Maneesh Sharma

  • Auditor

    Suresh Surana & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Piramal Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Piramal Pharma 198.45 5,444.74 4,782.01 37.73 10.77
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77